Methyl morpholine oxide → 5-bromo-3-methyl-1-(2-methylpropyl)-6-[(pyridin-3-yl)carbonyl]thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione
反応式
[Br:1][C:2]1[C:10]2[C:9](=[O:11])[N:8]([CH3:12])[C:7](=[O:13])[N:6]([CH2:14][CH:15]([CH3:17])[CH3:16])[C:5]=2[S:4][C:3]=1[CH:18]([OH:25])[C:19]1[CH:20]=[N:21][CH:22]=[CH:23][CH:24]=1.C[N+]1([O-])CCOCC1>ClCCl.[Ru]([O-])(=O)(=O)=O.C([N+](CCC)(CCC)CCC)CC>[Br:1][C:2]1[C:10]2[C:9](=[O:11])[N:8]([CH3:12])[C:7](=[O:13])[N:6]([CH2:14][CH:15]([CH3:17])[CH3:16])[C:5]=2[S:4][C:3]=1[C:18]([C:19]1[CH:20]=[N:21][CH:22]=[CH:23][CH:24]=1)=[O:25]参加物
5
反応物 2
生成物 1
試薬・触媒・溶媒 2
実験手順
A solution of 5-bromo-3-methyl-1-(2-methylpropyl)-6-[1-hydroxy-1-(pyridin-3-yl)methyl]thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione (0.50 g, Example 39 step b)), 4-methylmorpholine-N-oxide (0.21 g), powdered 4A sieves (0.58 g) and tetra-n-propylammoniumperruthenate (0.02 g) in dry dichloromethane (40 ml) was stirred for 1 hour at room temperature. The suspension was filtered through celite and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography over silica eluting with dichloromethane to give the subtitle compound as a cream solid (0.47 g).
後処理
- filtrationThe suspension was filtered through celite
- concentrationthe filtrate was concentrated under reduced pressure
- customThe residue was purified by column chromatography over silica eluting with dichloromethane
出典と根拠
- ORDレコード
- ord-ece7d5f2c15144529acabf523518caef
- 出典データセット
- uspto-grants-2001_10
- 特許番号
- US06300334B1
反応ノート
読み込み中…